Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome

Objectives To assess the variability and predictability of adiponectin, leptin, resistin and their ratios in non-obese and obese women with anovulatory polycystic ovary syndrome (aPCOS). Results A total of 52 ovulatory controls (mean age = 31.63 ± 4.88 years, BMI = 25.33 ± 2.68 kg/m2); 54 non-obese (mean age = 32.11 ± 4.25 years, BMI = 25.72 ± 2.95 kg/m2) and 50 obese women with aPCOS (mean age = 33.64 ± 4.14 years, BMI = 39.19 ± 2.99 kg/m2) were recruited. The aPCOS group had lower adiponectin [13.0 (10.49–16.59) vs 18.42 (15.72–19.92) µg/ml, p \u3c 0.0001], adiponectin: leptin ratio (A:L) [0.60 (0.35–0.88) vs 1.19 (0.92–1.37), p \u3c 0.0001], and adiponectin: resistin ratio (A:R) [0.30 (0.21–0.43) vs 0.42 (0.32–0.62), p \u3c 0.0001] but a higher leptin [20.02 (14.54–26.80) vs 16.17 (14.51–18.36) ng/ml, p \u3c 0.0001] and leptin: resistin ratio (L:R) [0.53 (0.37–0.82) vs 0.40 (0.27–0.48), p \u3c 0.0001] compared to the controls. The obese aPCOS group had lower adiponectin [11.04 (5.66–13.25) vs 14.18 (11.04–18.02), p \u3c 0.0001 and 18.42 (15.72–19.92) µg/ml, p \u3c 0.0001], A:L [0.36 (0.27–0.44) vs 0.78 (0.61–1.16), p \u3c 0.0001 and 1.19 (0.92–1.37), p \u3c 0.0001], and A:R [0.24 (0.17–0.38) vs 0.40 (0.23–0.58), p \u3c 0.0001 and 0.42 (0.32–0.62), p \u3c 0.0001] but a higher leptin [26.80 (14.28–32.09) vs 17.95 (14.86–21.26), p \u3c 0.05 and 16.17 (14.51–18.36) ng/ml, p \u3c 0.0001] and L:R [0.63 (0.46–1.03) vs 0.41 (0.30–0.61), p \u3c 0.0001 and 0.40 (0.27–0.48), p \u3c 0.0001] compared to the non-obese aPCOS and control group, respectively. A:L showed the best discriminatory power in predicting aPCOS (AUC = 0.83), followed by adiponectin alone (AUC = 0.79), L:R and leptin alone (both AUC = 0.69). Resistin alone had the poorest discriminatory power (AUC = 0.48)